Biologics: Targets and Therapy
Volume 7, 2013 - Issue
Open access
82
Views
4
CrossRef citations to date
0
Altmetric
Review
New and emerging treatments for ulcerative colitis: a focus on vedolizumab
Tamsin Gledhill1 Digestive Diseases Centre, Aintree University Hospital Trust, Liverpool, UK
& Keith Bodger2 Gastroenterology Department, Institute of Translational Medicine, University of Liverpool, Liverpool, UKCorrespondence[email protected]
Pages 123-130
|
Published online: 23 May 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.